The external use drug from muscle and joint pains :: Consumers survey results of for 1 quarter of 2010

Consumers survey results of for 1 quarter of 2010 in category

Musculo-skeletal system / The external use drug from muscle and joint pains

The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.

	I quarter (january—march)
	II quarter (april—june)
	III quarter (july—september)
	IV quarter (october—december)

1.	4	Форт-гель (Ternopharm)	28.57%	5

2.	5	Денебол гель (Mili Healthcare)	22.86%	4

3.	~	Диклак (Sandoz)	20.00%	3.50

4.	2	Фастум Гель (Berlin-Chemie Menarini)	17.14%	3

5.		Бен-Гей (Pfizer Inc.)	14.29%	2.50

5.	~	Ф-Гель (Darnitsa)	14.29%	2.50

7.	4	Traumeel S (Heel)	11.43%	2

7.	5	Аналгос (Riemser Arzneimittel)	11.43%	2

7.	3	Долобене (ratiopharm)	11.43%	2

7.	~	Олфен (Teva)	11.43%	2

7.	~	Розенталя паста (Ternopharm)	11.43%	2

7.	~	Терафлекс M (Bayer)	11.43%	2

7.	5	Хондрасіл (Farmak)	11.43%	2

14.	4	Voltaren (Novartis OTC)	8.57%	1.50

14.	3	Апізартрон (Esparma)	8.57%	1.50

14.	~	Диклофен-гель (Борщагівський ХФЗ)	8.57%	1.50

14.	3	Диклофенак (Hemofarm)	8.57%	1.50

14.	5	Дип Ріліф (Mentholatum)	8.57%	1.50

14.	2	Фіналгель (Boehringer Ingelheim)	8.57%	1.50

–.	4	~~Алором лінімент (Лубнифарм)~~	~~8.57%~~	~~1.50~~

–.	4	~~Мазь окопніка др. Тайсс (Naturprodukt Vega (Dr. Theiss Naturwaren GmbH))~~	~~8.57%~~	~~1.50~~

20.	~	Диклосан (Лубнифарм)	5.71%	1

20.	~	Еспол (Nizhpharm)	5.71%	1

20.	5	Ремісид (Darnitsa)	5.71%	1

20.	1	Фіналгон (Boehringer Ingelheim)	5.71%	1

24.	5	Бутадіон (Gedeon Richter)	2.86%	0.50

24.	5	Верал (Herbacos-Bofarma)	2.86%	0.50

24.	5	Випросал В (Grindex)	2.86%	0.50

24.	5	Диклофенак (Red star)	2.86%	0.50

24.	~	Димексид (Лубнифарм)	2.86%	0.50

24.	~	Дип Хіт (Delta Medical)	2.86%	0.50

24.	~	Доларен (Nabros Pharma)	2.86%	0.50

24.	4	Кетонал (Sandoz)	2.86%	0.50

24.	~	Ревма-гель (DHU)	2.86%	0.50

24.	~	Ревма-Мазь інтенсив др. Тайсс (Naturprodukt Vega (Dr. Theiss Naturwaren GmbH))	2.86%	0.50

24.	3	Хондроксид (Nizhpharm)	2.86%	0.50

–.	4	Індометацин (Sopharma)	0.00%	0

–.	5	Диклоран (Johnson & Johnson)	0.00%	0

–.		Димецин (Arterium Corporation)	0.00%	0

–.		Дип Фріз (Delta Medical)	0.00%	0

–.	5	Долгіт крем / гель (Dolorgiet GmbH & Co. KG)	0.00%	0

–.		Еспол (Red star)	0.00%	0

–.		Капсикам (Grindex)	0.00%	0

–.		Нікофлекс (Reanal)	0.00%	0

–.	5	Німулід (Panacea Biotec)	0.00%	0

–.		Найз (Nimesulid)	0.00%	0

–.		Наклофен (KRKA)	0.00%	0

–.		Репарил гель Н (Madaus)	0.00%	0

–.		Унгапівен (Red star)	0.00%	0

–.		~~Ібупрофен-Дарниця (Darnitsa)~~	~~0.00%~~	0

–.	5	~~Індометацин (Actavis)~~	~~0.00%~~	0

–.		~~Індометацин (Red star)~~	~~0.00%~~	0

–.	5	~~Димексид (Arterium Corporation)~~	~~0.00%~~	0

–.		~~Репарил Гель (Madaus)~~	~~0.00%~~	0

–.		~~Фелоран (Actavis)~~	~~0.00%~~	0

Using this rating is only possible with obligatory link to the source.

This rating was built as a result of the study of social preferences in 2010, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media.

Advanced reporting booklet about the study, including demographics of the respondents, by regional breakdown, information roll-call of ad hoc judges etc, can also be obtained from managers of the contest.